New ultrasound tool could spare heart attack patients a second procedure

NCT ID NCT07264881

First seen Dec 08, 2025 · Last updated Jun 23, 2026 · Updated 27 times

Summary

This study is testing a new tool called UFR, which uses ultrasound images to measure blockages in heart arteries during a heart attack. Currently, the most accurate method requires patients to return 30 days later for a second invasive procedure. The study will enroll 200 heart attack patients and follow them for one year to see if UFR can provide reliable measurements right away, potentially saving patients from an extra procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACS (ACUTE CORONARY SYNDROME) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University

    Beijing, Beijing Municipality, 100029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IVUS-based Fractional Flow Reserve (UFR) - a diagnostic test using ultrasound images to measure blockages

What this could lead to

If successful, this could allow doctors to assess all blockages during the initial heart attack procedure, eliminating the need for a second invasive test 30 days later.

What could go wrong

This is an early-stage study with only 200 participants, so results may not apply to everyone. The new tool might not be accurate enough to replace the current gold standard.

Conditions

The condition(s) this trial relates to.

acute chest syndrome acute coronary syndrome acute myocardial infarction coronary artery disorder Non-ST Elevated Myocardial Infarction ST-elevation myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.